Bank Julius Baer & Co
ABMD

Bank Julius Baer & Co’s Abiomed Inc ABMD Stock Holding History

Bank Julius Baer & Co’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-477
Closed -$118K – 638
2022
Q2 		$118K Hold
477
– – ﹤0.01% 475
2022
Q1 		$158K Hold
477
– – ﹤0.01% 446
2021
Q4 		$171K Sell
477
-101
-17% -$34.1K ﹤0.01% 542
2021
Q3 		$188K Buy
578
+17
+3% +$5.76K ﹤0.01% 550
2021
Q2 		$175K Sell
561
-6
-1% -$1.84K ﹤0.01% 579
2021
Q1 		$181K Sell
567
-183
-24% -$58.6K ﹤0.01% 547
2020
Q4 		$243K Sell
750
-3,635
-83% -$1.01M ﹤0.01% 540
2020
Q3 		$1.22M Sell
4,385
-457
-9% -$132K 0.01% 274
2020
Q2 		$1.17M Sell
4,842
-11
-0.2% -$2.21K 0.01% 253
2020
Q1 		$704K Buy
+4,853
New +$806K 0.02% 272

Other funds holding ABMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
Winslow Capital Management
Winslow Capital Management Minneapolis, Minnesota $25.6B AUM 33.75% 1-Year Est. Return

Bank Julius Baer & Co's ABMD Position: Q3 2022 in Review

Bank Julius Baer & Co sold out of Abiomed Inc (ABMD) in Q3 2022, closing a stake of 477 shares — an estimated $118K sold.

Bank Julius Baer & Co first reported a position in ABMD in Q1 2020 and held it in 10 quarters. The position peaked at $1.22M in Q3 2020. 517 funds tracked by Wall St. Rank hold ABMD as of Q3 2022.

  • Bank Julius Baer & Co reported no remaining Abiomed Inc position as of Q3 2022 after selling out during the quarter.
  • Bank Julius Baer & Co sold 477 Abiomed Inc shares in Q3 2022, an estimated $118K.
  • Bank Julius Baer & Co first reported a position in Abiomed Inc in Q1 2020 and held it in 10 quarters.
  • Bank Julius Baer & Co's Abiomed Inc position peaked at $1.22M in Q3 2020.
  • 517 funds tracked by Wall St. Rank held Abiomed Inc as of Q3 2022.

Based on Bank Julius Baer & Co's 13F filing for Q3 2022, filed 4 Nov 2022.